SOST deficiency is a dubious disease that belongs to the field of genetic metabolism, clinical performance is complex and often involves multi-systematic stress. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of SOST deficiency requires the development of multiple treatment programs, typically including drug therapy, rehabilitation interventions, and regular follow-up management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult to treat genetic metabolic disorders.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the lack of SOST. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.